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Transfusion of blood components is an irreplaceable 
form of treatment for many patients1. However, besides 
providing sufficient amounts of blood components of 
excellent quality, blood transfusion services should 
protect the safety of blood donors. Numerous studies 
have proven that iron deficiency is common in frequent 
blood donors, particularly women2-5. Determination of 
the haemoglobin concentration is a routine part of the 
donor selection process both in order to ensure adequate 
quality of red cell concentrates collected and to protect 
the potential donor's health. Indeed, low haemoglobin 
is globally the most common reason for deferral of 
prospective blood donors. Nevertheless, only cases of 
manifest low haemoglobin levels and imminent anaemia 
are detected using this approach. More sensitive tests 
are needed to assess depletion of iron stores, particularly 
in non-anaemic individuals, with ferritin measurements 
being used most frequently. 
Many studies to find the best approach to preventing 
iron deficiency in blood donors have been carried out or 
are still in progress6-9. These studies aim to re-evaluate 
current criteria in blood donor selection including the 
appropriateness of the interval between donations, to decide 
on the optimal testing strategy for determination of iron 
stores and to investigate the effect of iron supplementation 
in preserving them. The results of each study contribute 
to making decisions which should preserve an adequate 
blood supply without harming blood donors. 
This international forum was initiated to evaluate 
the algorithms of donor selection and care to avoid iron 
deficiency as well as the methods used in the assessment 
of iron status in blood donors.
The request for participation was sent to experts 
in 28 member states of the European Union, together 
with a short questionnaire containing eight questions. 
The response rate was high with 26 countries (92.9%) 
having responded to the forum. The data obtained are 
summarised below and followed by the individual 
contributions with more details. Participants were asked 
to indicate whether the information relates to the national 
or institutional/local level and to provide respective data 
if haematocrit is also assessed. Participants from most 
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countries provided national data (17/26), while others 
provided local or institutional data.
Question 1
Please describe the method of haemoglobin (Hb)
determination in donor selection:  
- do you apply an invasive or non-invasive method for 
routine donor haemoglobin screening? 
 Please specify the method(s) you are using. 
- If you are using two or more screening methods, can 
you estimate the proportion of each method at the 
national (or institutional/local) level? 
- Do you, and under what circumstances, use venous 
blood in donor haemoglobin assessment (e.g. pre- or 
post-donation? additional testing in the case of failing 
the initial screen? ...).
The methods used to determine haemoglobin in 
blood donors are summarised in Table I.
Four participants reported the use (or experience 
in using) non-invasive methods of haemoglobin 
determination. In two countries non-invasive 
technologies for determining haemoglobin concentration 
are under evaluation or are planned to be introduced in 
the near future.
Capillary blood is used for the determination of 
haemoglobin concentration in 24 of 26 countries that 
responded to the question. The copper sulphate test is 
used only in the United Kingdom, Spain and Croatia. A 
Table I - Haemoglobin determination in donor selection.
Country Reporting level Method(s) in use
Non-Invasive Invasive Sampling pouch
Capillary Venous Venous
Austria National Yes (minority) Yes Grey-zone/doubtful results Yes (1 centre)
Belgium National No
Yes (all new donors and 
failed Hb on previous 
donation)
No Yes (100%)
Bulgaria National No Yes No No
Croatia National Yes (14% in 2014) Yes (86% in 2014) No Yes (apheresis only)
Cyprus National No Yes Yes (apheresis only) No
Czech Republic Institutional No Yes Yes (new WB donors)
Yes (regular WB 
and apheresis donors)
Denmark Regional No No
Yes (low Hb 
on previous donation)
Yes
Estonia National No Yes No No
Finland National No Yes
Yes (deferred due to low 
capillary)
No
France National No Yes (21%) Yes (low capillary) Yes (100%)
Germany Regional No Yes No No
Greece National Yes (1 centre) Yes No
Yes (apheresis donors and 
some first time female donors)
Italy Local No Yes Yes (low capillary) Yes (100%)
Latvia National No Yes No No
Lithuania Institutional No Yes No No
Luxembourg National No Yes ("trigger events")
Yes (donor candidates and 
"trigger events")
Yes 
Malta National No Yes
Yes (low capillary and 
apheresis)
No
Netherlands National No Yes No (only special request)
No (for quality control 
purposes only)
Poland National Yes Yes
Yes (once yearly for
regular donors)
No
Portugal Local No Yes Yes (apheresis donors) Yes (first time WB donors)
Romania Institutional No Yes
Yes (apheresis donors or 
suspicious capillary level)
No
Slovakia National No Yes (mobile collections) Yes (donations at BE)
Yes (donors tested only 
from capillary blood)
Slovenia National No Yes 98% Yes 2% (apheresis) No
Spain Regional No (starting 2016) Yes Yes (low capillary) No
Sweden National No (under evaluation) No Yes (candidate donors) Yes (registered donors)
United Kingdom National No Yes Yes (low capillary) No
WB: whole blood; BE: blood establishment; Hb: haemoglobin.
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photometric measurement of haemoglobin in capillary 
blood was reported by 21 participants, of which 14 use 
the HemoCue® method (HemoCue AB, Angelholm, 
Sweden). One country uses both methods, copper 
sulphate and HemoCue®.
Seventeen participants reported invasive sampling 
of venous blood for haemoglobin determination, almost 
exclusively in cases of donors deferred due to the low 
capillary haemoglobin and new/candidate donors, but 
seldom in apheresis donors. Non-invasive sampling of 
venous blood from the sampling pouch during donation is 
standard procedure for donors in apheresis programmes. 
However, this method is also in use for whole blood 
donors: nine participants reported such procedure for all 
donors and one participant for new donors.
Question 2
What are the minimum haemoglobin levels for male and 
female donors to donate:
- whole blood;
- platelets/plasma;
- red cells by apheresis.
In all countries except France (25/26), minimum 
haemoglobin levels for whole blood donations are 
the same: 125 g/L for female and 135 g/L for male 
donors. In France, these levels are 120 g/L and 130 g/L, 
respectively. 
For plasma collection, 18 of 24 participants reported 
minimum haemoglobin levels of 125 g/L for female 
and 135 g/L for male donors, three participants 120 g/L 
and 130 g/L and two participants 115 g/L and 125 g/L, 
respectively. Only in Austria is the minimum value for 
both sexes the same, at 120 g/L. 
For platelet apheresis, 22 of 26 participants reported 
minimum haemoglobin levels of 125 g/L for female 
and 135 g/L for male donors, two participants 120 g/L 
and 130 g/L, and one participant 115 g/L and 125 g/L, 
respectively. Romania reported two different standards 
in use, depending on the type of the apheresis machine 
(120-125 g/L for female donors and 130-135 g/L for 
male donors).
Seventeen participants reported minimum 
haemoglobin values for red cells obtained by apheresis: 
eight of them 140 g/L for both sexes, 150 g/L in Slovakia 
(only male donors) and Italy. Another six paricipants 
reported the same values as for whole blood donations 
(125 g/L and 135 g/L in female and male donors, 
respectively). Lithuania reported different values for 
male (140 g/L) and female donors (145 g/L).   
Question 3
What is the donor deferral rate due to low haemoglobin? 
If possible, please provide the information for 2014, 
separately for male and for female donors.
Six participants could not provide data on donor 
deferral for low haemoglobin, while another seven 
participants did not have data separately for male and 
female donors. Among 13 participants reporting data for 
both sexes, the deferral rate for female donors ranged 
from 0.84% in Denmark to 15.9% in Croatia, while 
for male donors deferral rates ranged from 0.11% in 
Denmark to 3.24% in Croatia. For female donors, eight 
out of 13 participants reported deferral rates from 3.77 
to 5.49%, three participants from 8.5 to 15.9% and two 
participants from 0.84 to 1.40%. 
For male donors, three participants reported deferral 
rates below 1%, seven participants reported rates from 
1.0 to 2.0% and three participants reported deferral rates 
from 2.8 to 3.24%. 
Question 4
What is the minimal interval between whole blood 
donations (separately for males and females if different) 
and what is the maximum number of donations that 
can be collected from male and from female donors in 
a 1-year period?
The responses to this question are summarised in 
Table II, including reporting level. 
In 17/26 countries intervals for blood donations 
are the same for male and female donors, while in 
the remaining nine countries intervals for male and 
female donors differ by 20-30 days. For female donors 
the interval between two donations is 2 months in 11 
countries, between 2-3 months in two countries, 3 
months in six countries, and 4 months in seven other 
countries. For male donors the interval between two 
donations is 2 months in 12 countries, between 2-3 
months in three countries, and 3 months in 11 countries.
The annual frequency of whole blood donations 
ranges from two to four for female donors and 
from four to six donations for male donors. In Italy, 
females are allowed to donate only twice per year. 
In Austria, it is not the number of donations that is 
regulated by law but the maximum volume to be 
collected per year, which is 3,000 mL/year for men, 
2,000 mL/year for women before the menopause 
and 3,000 mL/year for post-menopausal women. In 
Belgium, a fifth donation is allowed by law in case 
of special medical need.
Question 5
What is the acceptable range for the volume of whole 
blood donations? If possible, please specify both the 
volume of the unit and volume of the blood collected 
for laboratory testing.
Most participants (18/26) reported the target volume 
of 450 mL, while an additional 10-40 mL are collected for 
laboratory testing. The data are summarised in Table II.
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Question 6
Do you routinely use a ferritin test (or another 
appropriate test -in this case please specify) in assessing 
donor iron stores? If so, what algorithm are you using 
for detecting/monitoring iron deficiency (please describe 
briefly)? Please provide information on the frequency 
of iron deficiency detected in male and female donors. 
If not used routinely, are you aware of any research on 
donor iron stores in your country?
Ten participants reported varying degrees of ferritin 
testing. In Denmark, the Czech Republic and Italy 
ferritin is measured to a greater extent. In Denmark 
(regional data) ferritin testing is performed in all first 
time donors, on every tenth donation and in the case of 
previously low or high ferritin or haemoglobin. In the 
Czech Republic (institutional data), ferritin is measured 
in all new blood donors and in selected cases of repeat 
donors. In Italy (local data), ferritin is measured once 
yearly in regular donors, while in Cyprus different tests 
are performed once a year (complete blood count, iron, 
ferritin). 
In seven countries (Austria, Croatia, France, Malta, 
The Netherlands, Portugal and UK) research on donor 
iron stores has been carried out or is in progress.
Question 7
Please describe briefly how you are managing donors 
with iron deficiency (donation intervals, future 
donations, counselling, dietary advice, treatment, etc.)
The most common answers to this question were: 
referral of donors to a general practitioner/specialist, 
donor deferral and prolongation of the donation interval, 
followed by donor counselling and giving dietary advice. 
Five participants reported determination of iron stores. 
Table II - Donation interval, frequency and volume.
Country Reporting level Interval1 Donations/year Volume collected (mL)
Females Males Females Males Units Samples
Austria National 8 weeks 8 weeks - - 450±10% 40 
Belgium National/Institutional* 2 months 2 months 4 4 max 470* max 30*
Bulgaria National 2 months 2 months 4 5 450±10% 17 
Croatia National 4 months 3 months 3 4 450±10% 35 
Cyprus National 120 days 90 days 3 4 450±10% ≤10 
Chech Republic Institutional 10 weeks 10 weeks 4 5 450 target max 20 
Denmark Regional 90 days 90 days 4 4 450±10% approx. 40 
Estonia National 2 months 2 months 4 6 450±10% approx. 35 
Finland National 91 days 61 days 4 6 465 target (415-515) 30 
France National 8 weeks 8 weeks 4 6 max 500 
(not >13% TBV)
30-40 
Germany Regional 56 days 56 days 4 6 target 500 max 30 
Greece National 2 months 2 months 3-4 4-6 450±20 20-30 
Italy Local 90 days 90 days 2 4 450 target max 40 
Latvia National 9 weeks 9 weeks 4 6 450 35 
Lithuania National/Institutional* 2 months 2 months 4 6 405-495* 20* 
Luxembourg National 4 months 3 months 3 4 500±10% 30 
Malta National 4 months 3 months 3 4 475±10% 10-15 
Netherlands National 8 weeks 8 weeks 3 5 450-550 30 
Poland National 8 weeks 8 weeks 4 6 450±10% approx. 40 
Portugal Local 4 months 3 months 3 4 450±10% 35 
Romania Institutional 90 days 70 days 4 5 450±10% approx. 18
Slovakia National 4 months 3 months 3 4 450 target 25 
Slovenia National 4 months 3 months 3 4 450±10% 23 
Spain Regional 2 months 2 months 3 4 411-495 24 
Sweden National 12 weeks 12 weeks 3 4 450±10% no data
United Kingdom National 12 weeks 12 weeks 7 times in 2 years (advise) 475±10% 20-35
1: Data reported as per individual contributions; *Institutional data; TBV: total blood volume.
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Iron supplementation practices were investigated further 
in the next question. 
Question 8
If iron supplementation is given, please specify:
- whether the therapy is given orally or intravenously;
- who bears the costs of the iron therapy.
Respondents from 14 of the 26 countries reported 
the use of iron supplementation to varying degrees. 
Supplemental iron is administered orally, and, in most 
cases, the costs are covered by blood transfusion services.
Haematocrit measurements are not routine practice in 
donor selection in member states of the European Union. In 
Austria, haematocrit measurements are allowed but seldom 
performed (reference value for males is 0.4 and for females 
0.38). In Denmark (regional data), if the haematocrit is 
>0.52 on two occasions, the donor is referred to a general 
practitioner or haematologist. For plasmapheresis the 
haematocrit should be <0.50, as long as the haemoglobin 
concentration is in the acceptable range.  
Conclusion
Overall, the results indicate still limited use of 
non-invasive methods for determining blood donors' 
haemoglobin concentration and the predominance of 
photometric measurements in capillary blood samples. 
Minimum haemoglobin levels to donate blood and 
blood components are nearly identical among member 
states, which is not surprising given the corresponding 
requirements in the European Union Directive 2004/33/
EC. However, clear differences exist when comparing the 
minimal intervals between whole blood donations and 
the maximum number of donations that can be collected 
annually. This may explain, at least partially, the different 
rates of donor rejections due to the low haemoglobin. 
Despite the great interest of professionals in this topic, 
relatively few studies have been conducted to investigate 
iron stores in blood donors in the European Union. 
Although 38% of participants use ferritin measurement, 
this method is implemented on a larger scale in only three 
countries. Although a majority of participants (14/26) use 
supplementation as a means to manage iron deficiency 
in blood donors, there are important differences in the 
approaches to administering supplementary iron to prevent 
or correct iron deficiency.
It would be useful to organise a consensus conference 
and issue guidelines to facilitate decision-making on the 
assessment, prevention and treatment of iron deficiency 
in blood donors. It is to be hoped that the results of this 
international forum will serve as an incentive for such 
an initiative.
The individual contributions from the 26 countries 
are presented below.
The Authors declare no conflict of interests.
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AUSTRIA
Introduction 
Austria has nine federal states and 8,474,00 inhabitants 
(2013 census). The population of the federal states determines 
the size of the ten regional blood centres. The Red Cross 
started its first blood donation service in 1950. Since then 95% 
of blood donations have been carried out by the Red Cross. 
Approximately 60% of the annual 300,000 to 340,000 whole 
blood units are further prepared and tested in Red Cross blood 
centres. The remaining 40% are produced in hospitals, of which 
two sites are university institutes, one site a hospital-based 
institute in close relationship with a medical university and the 
remaining three sites are hospital-based centres1. The following 
statements refer to the situation in the whole of Austria.
Question 1 (Hb determination in donor selection)
Until 2012 Hb tests on Austrian blood donors were mostly 
performed using capillary blood gained by finger or ear sticks. 
In 2012 the Central Institute of Blood Transfusion in Innsbruck 
implemented the non-invasive Hb measurement method NBM 200 
(OrSense ltd, NesZiona, Israel). The system was validated against 
an automated haematology cell analyser (Sysmex XS-1000i, Cobe, 
Japan) serving as a gold standard and was also compared to the 
invasive method in use (HemoCue®). After intensive training of 
the personnel, specificity of the system was 97.6% and sensitivity 
98.6% with regard to the reference values, correlation to the gold 
standard was 0.761 for both methods, invasive and non-invasive 
(data presented as poster at the AABB annual meeting 2012). In 
2015 the majority of the Austrian blood donor services changed 
to non-invasive methods. Two devices were in use: NBM 200 
and Haemospect®(MBR Optical Systems, Wuppertal, Germany). 
Because of recent problems with the sensitivity and  specificity of 
the Haemospect® system in 2016 users of this system changed back 
to invasive  methods. One blood centre still takes intravenous blood 
samples drawn from the connector of the blood bag system and 
testing is performed by an automated haematology cell analyser. 
Tests giving grey-zone results or implausible results (obvious 
difference between the donor`s clinical appearance and Hb value 
or results of previous measurements) are repeated on site and, if 
necessary, confirmed by an automated haematology cell analyser 
in the blood establishment or in a specialised laboratory.
Question 2 (Minimum Hb levels)
According to the Blood Safety Act 19992 and the Blood 
Donor Order 19993 all blood donors must be tested on signs 
of anaemia. This must be done before the donation using 
a test measuring the Hb value. World Health Organisation 
reference values for cellular components and single unit 
red cell apheresis donors are 125 g/L for female donors and 
135 g/L for male donors. For double unit red cell apheresis 
donations a minimum Hb level of 140 g/L is required for 
both sexes. For plasma the reference value for both sexes is 
120 g/L. Haematocrit measurement is also allowed but is 
seldom performed (reference value for men: 0.4 and for 
women: 0.38).
Question 3 (Donor deferral rate for low Hb)
Exact numbers are not available, but the deferral rate is 
estimated to be in the range of less than 1%, including a high 
proportion of pre-menopausal women.
Question 4 (Donation intervals and frequencies)
The minimal interval between two whole blood donations for 
both female and male donors is 8 weeks. It is not the number of 
donations that is regulated by law but the maximum volume to be 
collected per year: men, 3,000 mL/year; women before menopause, 
2,000 mL/year; and women after the menopause 3,000 mL/year.
Question 5 (Volume of whole blood donations)
The standard volume of whole blood collected is 
450 mL±10%. Another 40 mL are drawn for testing by use of 
the device´s sampling bag.
Question 6 (Assessment of iron stores)
Routine measurement of ferritin or a comparable test is 
not mandatory in Austria. In 2013, for her master's thesis, 
Schuessler S enrolled 2,594 whole blood donors from 
the Austrian federal state Upper Austria. All of them had 
appropriate Hb levels and were tested for ferritin, transferrin 
saturation and various red blood cell indices. The overall 
prevalence of iron deficiency in this donor population was 
22.8%: pre-menopausal women were iron deficient in 39.1% 
of cases and post-menopausal women in 23.6% of cases. The 
odds ratio for being iron deficient between female and male 
donors was 3.76. Men who donated more than four times per 
year showed a statistically significant higher prevalence of iron 
deficiency than men who made fewer donations.
Question 7 (Managing donors with iron deficiency) and 
Question 8 (Iron supplementation)
Donors who attract attention because of symptoms or low 
Hb levels undergo testing of their iron stores. If the results 
are outside the normal range the donor is first excluded from 
further donations and then referred to a general practitioner 
or a specialist in internal medicine. In most cases the donor 
will undergo more extensive investigation, followed by 
iron supplementation with oral or intravenous iron, usually 
prescribed by the general practitioner and only rarely by a 
specialist in transfusion medicine in the blood establishment. 
The Austrian health and welfare system bears the cost of the 
iron supplementation.
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and females. In case of special medical needs, a fifth whole 
blood donation is allowed by law.
Question 5 (Volume of whole blood donations)
The maximum volume collected must not exceed 13% of 
the donor's estimated total blood volume, with a maximum 
of 500 mL per donation. At our Blood Service the maximum 
volume is 470 mL. In addition, up to 30 mL are collected for 
laboratory tests by way of the in-line diversion pouch.
Question 6 (Assessment of iron stores)
At present no tests to assess donor iron stores are in use 
and we are not aware of any such tests in Belgium.
Question 7 (Managing donors with iron deficiency)
Iron deficiency is indicated as a possible long-term adverse 
effect in our educational material given to all donors. In this 
material, special attention is given to female donors in their 
fertile period. Donors with a low venous Hb level are informed 
and referred to their physician for follow-up. At the next 
donation, these donors are screened before donation using a 
capillary method and dietary advice is given on how to prevent 
this in the future.
Question 8 (Iron supplementation)
A Ministerial Decree permits the supplementation of iron 
for female whole blood donors in the fertile age group. At our 
blood service a blister of 15 tablets containing 105 mg Fe++ per 
tablet is provided. The costs are borne by the Blood Service. 
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BULGARIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
An invasive method is applied to determine Hb levels. 
Only one method is used, the microcuvette method (HemoCue® 
system).
Question 2 (Minimum Hb levels)
- Whole blood: males ≥135 g/L; females ≥125 g/L;
- platelets/plasma: males ≥135 g/L; females ≥125 g/L;
- red cells by apheresis: red cells are not collected by 
apheresis.
2) Bundesgesetz: Über die Gewinnung von Blut- 
und Blutbestandteilen in Blutspendeeinrichtungen 
(Blutsicherheitsgesetz 1999 -BSG 1999, NR: GP 
XX RV 1430 AB 1577 S.156. BR: AB 5867 S.650), 
Bundesgesetzblattfür die RepublikÖsterreich, Jahrgang 
1999, Teil I, ausgegeben am 10. März 1999 [in German].
3) Verordnung der BundesministerinfürArbeit, Gesundheit 
und Sozialesbetreffend den Gesundheitsschutz von 
Spendern und die Qualitätssicherung von Blut- und 
Blutbestandteilen (Blutspenderverordnung-BSV), 
Bundesgesetzblattfür die RepublikÖsterreich, Jahrgang 
1999, Teil II, ausgegeben am 30. März 1999 [in German].
Contact details
Harald Schennach
Central Institute for Blood Transfusion and Dept. of Immunology 
Tirol Kliniken GmbH www.tirol-kliniken.at
Anichstrasse 35
6020 Innsbruck, Austria 
e-mail:harald.schennach@tirol-kliniken.at
BELGIUM
The data reported refer to the national or institutional* level.
Question 1 (Hb determination in donor selection)
Belgian law prescribes that total blood counts, including 
Hb levels, should be determined at each donation (pre- or 
post-donation). Venous samples are collected by way of the 
integrated sample pouch. In mid-2015 a capillary method 
for Hb measurement (Compolab TS haemoglobin screening 
device, Fresenius Kabi) was added before collection for all 
new donors and for repeat donors with a low Hb level at the 
previous donation.
Question 2 (Minimum Hb levels)
In accordance with Directive 2004/33/EC, Belgian Law 
details that the minimal acceptable levels of Hb for whole 
blood and cellular components collected by apheresis 
should be 125 g/L for female donors and 135 g/L for male 
donors. A higher minimum Hb concentration of 140 g/L is 
required for double unit red cell apheresis. The minimum 
value for plasmapheresis is 120 g/L for female donors 
and 130 g/L for male donors. At present no red cells are 
collected by apheresis.
Question 3 (Donor deferral rate for low Hb)
Overall in 2014, 5.74% of whole blood donors were 
deferred because of low Hb levels (9.1% of female donors and 
2.8% of male donors)*. 
Question 4 (Donation intervals and frequencies)
Donors are allowed to donate whole blood four times a year. 
The interval between two whole blood donations should not 
be less than 2 months. No difference is made between males 
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Question 3 (Donor deferral rate for low Hb)
No data available.
Question 4 (Donation intervals and frequencies)
- Males: maximum five donations in a 1-year period; the 
minimal interval between whole blood donations is 2 months.
- Females: maximum four donations in a 1-year period; 
the minimal interval between whole blood donations is 2 
months.
Question 5 (Volume of whole blood donations)
The accepted range of volume of a unit of whole blood is 
450 mL±10%.
The volume of blood collected for laboratory testing is 
17 mL.
Question 6 (Assessment of iron stores)
Ferritin is not measured and other tests are not performed.
Question 7: (Managing donors with iron deficiency)
When the Hb level is below the limit we apply the following 
measures:
- prolongation of donation interval;
- dietary advice;
- referral to general physician.
Question 8 (Iron supplementation)
Iron supplementation is not provided by blood transfusion 
services.
Contact details
Natalia Masharova
National Centre of Transfusion Haematology
112 "BratyaMiladinovi"str. 1202 
Sofia, Bulgaria 
e-mail: Nathalie_54@abv.bg
CROATIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
In Croatia, routine Hb screening in blood donors is 
performed before donation, mainly using an invasive method. 
In 2014, a copper sulphate test was used for 83% of donors, 
a further 3% were tested using the HemoCue® photometer. A 
non-invasive method (Hemospect®) was used in the remaining 
14% of donors (one centre), but its use was interrupted 
in 2015. Hb in venous blood is determined as part of the 
complete blood count in donors participating in an apheresis 
programme. On rare occasions, Hb is determined in venous 
blood as part of different studies and validations. In all such 
cases samples are taken from the sampling pouch integrated 
in the collection system.
Question 2 (Minimum Hb levels):
To donate whole blood or platelets/plasma using apheresis 
technology, the Hb level should be at least 125 g/L for female 
and 135 g/L for male donors. At present, red cells are not 
collected by apheresis in our country.
Question 3 (Donor deferral rate for low Hb)
In 2014 the total rate of deferrals because of low Hb was 
5.64% on the national level. The deferral rate was higher for 
female donors (15.9%) than for male donors (3.24%). All 
values are calculated as percentages of presenting donors.
Question 4 (Donation intervals and frequencies)
The minimum interval between whole blood donations 
is 3 months for male and 4 months for female donors. It is 
acceptable for both male and female donors to donate blood up 
to 7 days prior to the above mentioned periods. Accordingly, 
the maximum number of donations is four per year for male 
and three per year for female donors.
Question 5 (Volume of whole blood donations)
The acceptable range for the volume of whole blood 
donations is 405-495 mL (450 mL±10%) plus approximately 
35 mL of blood in the diversion pouch used to collect samples 
for laboratory testing.
Question 6 (Assessment of iron stores)
No additional tests for the assessment of donor iron stores 
are in use so far. However,  extensive research on iron status 
in Croatian blood donors was completed recently and the 
data obtained will be used to decide on the implementation of 
ferritin measurement.
Question 7 (Managing donors with iron deficiency)
Donor deferral and counselling are currently the routine 
measures at our blood establishments.
Question 8 (Iron supplementation)
No iron supplementation is prescribed at donor sessions. 
Contact details
Tomislav Vuk
Quality Assurance
Croatian Institute of Transfusion Medicine
Petrova 3, 10000 Zagreb, Croatia
e-mail: tomislav.vuk@hztm.hr
CYPRUS
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
We apply an invasive method for routine donor Hb 
screening. A small drop of capillary blood is taken from the 
finger of a potential blood donor. The Hb concentration is 
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determined through a photometric method. This method uses 
a digital haemoglobinometer, which is a portable, battery-
operated photometric device based on determination of azide 
methaemoglobin. This method is implemented on a national 
level always before a blood donation. Venous blood is only 
taken in the case of platelet donors before the apheresis 
procedure in order to run a full blood count. A separate puncture 
is done before the apheresis procedure itself.
Question 2 (Minimum Hb levels)
For whole blood and platelet/plasma donations, the 
minimum Hb levels are 13.5 g/dL for males and 12.5 g/dL 
for females.
Red cell apheresis is not performed in our blood centres.
Question 3 (Donor deferral rate for low Hb)
The total donor deferral rate for 2014 was 14%; in 5% of 
cases the deferral was due to low Hb level for both men and 
women. The deferral rate for women was 4%, while that for 
men was 1%. Thirty-seven percent of all deferrals (men and 
women) were because of low Hb levels.
Question 4 (Donation intervals and frequencies)
The minimal interval between whole blood donations is: 
90 days for males and 120 days for females.
The maximum number of donations that can be collected 
in a 1-year period is four for males and three for females.
Question 5 (Volume of whole blood donations)
The volume of a unit of whole blood is 450 mL±45 (10%). 
The volume of blood for laboratory testing is ≤10 mL.
Question 6 (Assessment of iron stores)
Blood donors are offered a set of blood tests once a year 
and these include a full blood count, iron levels, ferritin levels 
and iron-binding capacity. Based on these results, blood donors 
are temporarily deferred from donation in the case of low iron 
and ferritin levels and are also advised on how to increase 
these parameters. The frequency of iron deficiency detected is 
approximately 7% in male donors and 15% in female donors.
Question 7 (Managing donors with iron deficiency)
Donors with iron deficiency are:
- temporarily deferred for 3 months, depending on their iron 
levels;
- future donations are postponed until iron levels return to 
normal;
- advised to increase their dietary iron intake by consuming 
specific groups of food; 
- advised to start on oral iron supplementation for 3 months 
at least, if necessary;
- counselled and referred to their general practitioner (GP), in 
the case of any other blood loss or serious iron deficiency 
and anaemia.
Question 8 (Iron supplementation)
Iron supplementation is given orally. The blood donor bears 
the cost of iron therapy. The blood transfusion service does not 
prescribe iron supplementation, blood donors are referred  to 
their general practitioners.
Comments and suggestions
We are interested in collecting some background information 
concerning the non-invasive methods for Hb estimation. 
Contact details
Karakatsiani Georgia
Isabella Argyrou
Cyprus Blood Establishment
Nicosia General Hospital Nicosia
Limassol Old Road No. 215, 
2029 Strovolos, Nicosia, Cyprus
CZECH REPUBLIC
The data reported refer to the Transfusion Department, 
University Hospitál Hradec Králové (annually 20,000 whole 
blood donations, 15,000 aphereses).
Question 1 (Hb determination in donor selection)
a) Whole blood first-time donors (6%): 
 - complete blood count before donation;
 - invasive-venous blood.
b) Whole blood regular donors (94%):
 - Hb before donation (HemoCue®);
 - invasive-capillary blood + post-donation complete 
blood count from the tube withdrawn at the beginning 
of the whole blood donation.
c) Apheresis donors (plasma, platelets):
 - non-invasive, complete blood count is measured from 
the tube withdrawn at the beginning of the procedure 
(apheresis donors are "qualified" donors, never first-
time donors).
d) Red cell apheresis = b)  (never first-time donors).
Question 2 (Minimum Hb levels)
- Whole blood:  males ≥135 g/L, females ≥125 g/L;
- plasma/platelets by apheresis: males ≥130 g/L, females 
≥120 g/L;
- double red cell apheresis: males and females ≥141 g/L.
Question 3 (Donor deferral rate for low Hb)
In 2014 the donor deferral rates for low Hb were 1.40% 
among female donors and 0.24% among male ones.
Question 4 (Donation intervals and frequencies)
The minimum donation interval is 10 weeks for both male 
and female donors.
Males may donate a maximum of five times/year, female 
a maximum of four times/year.
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Question 5 (Volume of whole blood donations)
The volume of a whole blood donation from both males and 
females is 450 mL + a maximum of 20 mL (from the satellite 
bag) for testing.
Question 6 (Assessment of iron stores)
Ferritin levels are determined in:
- all first time donors;
- repeat donors;
 in the case of an unexpected drop of Hb, for the donation 
subsequent to a delivery (female), and for donors 
undergoing double red cell apheresis.
Question 7 (Managing donors with iron deficiency)
All donors with iron deficiency are given dietary advice 
and counselling, their next donations are postponed and they 
can make a maximum of one or two whole blood donations/
year. Iron supplementation is given p.o. In the case of severe 
iron deficiency/anaemia, the individual is referred to the 
Haematology Department.
Question 8 (Iron supplementation)
Oral iron supplementation is given.
The costs are borne by the Transfusion Department. In 
the case of severe iron deficiency anaemia with referral of 
the donor to the Haematology Department, the expenses are 
covered by health insurance.
Contact details
Vít Řeháček
Transfusion Department,
University Hospital Hradec Králové
Sokolská 581
500 05 Hradec Králové, Czech Republic
e-mail: rehacekv@lfhk.cuni.cz
DENMARK
The data reported refer to regional data, from the Capital 
region in Denmark.
Question 1 (Hb determination in donor selection)
An invasive method is used to determine the donors' Hb.
An EDTA sample is taken from the pre-sample bag. The 
sample is sent to the Centre for Donor Haemoglobin and Iron, 
where it is analysed on a Sysmex XE2100-D (Sysmex Europe 
GmbH, Norderstedt, Germany) within 24 hours. If the Hb at 
the previous donation was low, the Hb is measured on a venous 
sample taken from the pouch, or directly from the arm and 
measured immediately on a PocH100i (Sysmex Europe GmbH, 
Norderstedt, Germany), and the donor is then only bled if the 
Hb is at least 7.8 mmol/L (125 g/L) for female donors and at 
least 8.4 mmol/L (135 g/L) for male donors. The donors whose 
Hb is measured pre-donation on the PocH100i will all have a 
control measurement on the Sysmex XE2100-D. 
The measurement is routinely available post-donation. 
All donors routinely have a complete blood count, and in 
some ferritin is also assayed, so no testing is done beyond 
that. 
Question 2 (Minimum Hb levels)
- whole blood: female donors 7.8 mmol/L and male donors 
8.4 mmol/L;
- platelets/plasma: as for whole blood, but with the possibility 
of approving levels down to 7.0 mmol/L (113 g/L) for 
female donors and down to 7.8 mmol/L (125 g/L) for male 
donors, only if the donors are healthy and cleared by the 
Donor Haemoglobin and Iron physician; 
- red cells by apheresis: not applicable.
The haematocrit is measured as part of the complete blood 
count, but is not our primary measure. If the haematocrit is 
>0.52 on two occasions the donor is referred to either a general 
physician (GP) or haematologist. Likewise, for plasmapheresis 
donors the haematocrit should be <0.50 and, as long as the 
Hb level is acceptable, the lower the haematocrit, the better.
Question 3 (Donor deferral rate for low Hb)
In 2014 the rate for female donors was 0.84%, while that 
for male donors was 0.11%.
Question 4 (Donation intervals and frequencies)
The intervals and frequencies are the same for male and 
female donors. The minimum interval is 90 days, which is 
equivalent to four times in 360 days; it is, therefore, possible 
for a few donors to donate five times in 1 year, if they donated 
during the first days of January.  
Question 5 (Volume of whole blood donations)
The volume of a unit of blood is 450 mL±10%; an 
additional 40 mL sample is used for tests.
Question 6 (Assessment of iron stores)
Ferritin is measured in first-time donors and the 
measurement is repeated every tenth donation. A control ferritin 
determination is also made when the previous ferritin or Hb was 
low or high. This strategy was started in a few blood banks in 
February 2011 but with no electronic transfer of results. From 
February 1st 2012 the programme was fully implemented.
Unfortunately we do not have any data on the current 
frequency of iron deficiency.
Question 7 (Managing donors with iron deficiency)
The same management is applied to male and female 
donors.
In the case of normal Hb and 
- ferritin <60 μg/L: the donor is offered 20 iron tablets with 
future donations;
-  ferritin <30 μg/L: the donor is also sent 60 iron-tablets by 
post.
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In the case of low Hb the donor is telephoned and
-  if disease is suspected, the donor is referred to the GP;
-  if there is no suspicion of disease, and 
 - ferritin <60 μg/L: the donor is offered 20 iron tablets 
with future donations,
 - ferritin <15 μg/L: the donor is sent 100 iron tablets by 
post 
 - ferritin 15-40 μg/L: the donor is sent 60 iron tablets by 
post 
 - ferritin >40 μg/L or not done: the donor is almost 
always referred to the GP.
Question 8 (Iron supplementation)
Iron supplementation is given orally, either as ferrous 
fumarate (100 mg iron) with vitamin C, or as bisglycinate 
with 25 mg iron.
The blood centre bears the cost of the iron therapy.
Contact details
Karin Magnussen
Centre for Donor Haemoglobin and Iron
Copenhagen University Hospital, Rigshospitalet
Blood Centre sec 231 - Hvidovre Hospital 
2650 Hvidovre, Denmark
e-mail: Karin.Magnussen@regionh.dk
ESTONIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
We apply an invasive method for routine donor Hb 
screening. We measure the level of Hb in donors' capillary 
blood (finger stick blood samples) using a Hb analyser. We do 
not use two or more screening methods. We do not use venous 
blood to assess donors' Hb concentration.
Question 2 (Minimum Hb levels)
- Whole blood: females 125 g/L, males 135 g/L;
- platelets/plasma:  females 125 g/L,  males 135 g/L;
- red cells by apheresis: females 140 g/L, males 140 g/L.
Question 3 (Donor deferral rate for low Hb)
In 2014 the donor deferral rate due to a low Hb was 7.2%.
Question 4 (Donation intervals and frequencies)
The minimal interval between whole blood donations is 2 
months. The maximum number of whole blood donations that 
can be collected from male donors in a 1-year period is six and 
from female donors is four.
Question 5 (Volume of whole blood donations)
The volume of the unit is 450 mL±10%; the volume of 
the blood collected for laboratory testing is approximately 
35 mL. 
Question 6 (Assessment of iron stores)
We do not measure ferritin; as of present we do not have 
any research on donor iron stores in our country.
Question 7 (Managing donors with iron deficiency)
We advise an iron-rich diet, use donor deferral and extend 
donation intervals. If the Hb level is very low or the low Hb 
lasts a long time, we recommend that the donor contacts his 
or her physician).
Question 8 (Iron supplementation)
We do not administer iron to donors.
Contact details
Gulara Khanirzajeva
North Estonia Medical Centre's Blood Centre
Collection and Production Department
2 Ädalastr
10614 Tallinn, Estonia
e-mail: Gulara.Khanirzajeva@regionaalhaigla.ee
FINLAND
The data reported are provided by the Finnish Red Cross 
Blood Service. 
Question 1 (Hb determination in donor selection)
Before every donation, a finger stick capillary blood sample 
is analysed with the point-of-care HemoCue® Hb201+ system.
A venous blood sample is used for blood count testing in 
deferred donors, when their Hb level in the screening test is 
<115 g/L (females) or <125 g/L (males).
Question 2 (Minimum Hb levels)
The minimal acceptable level of Hb in males (for all types 
of donation) is 135 g/L. 
The minimal acceptable level of Hb in females (for all 
types of donation) is 125 g/L.
Question 3 (Donor deferral rate for low Hb)
The deferral rate due to a low Hb level in 2014 was 1.5% 
in males and 4.1% in females.
Question 4 (Donation intervals and frequencies)
The maximum number of whole blood donations per year 
for male donors is six, with a minimum interval between 
donations of 61 days.
The maximum number of whole blood donations per year 
for female donors is four, with a minimum interval between 
donations of 91 days.
Question 5 (Volume of whole blood donations)
The targeted volume in whole blood collection is 465 mL; 
the acceptable range of volume is 415-515 mL (+ 30 mL sample 
for the laboratory testing).
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Question 6 (Assessment of iron stores)
We do not measure ferritin or other iron markers in donors.
Question 7 (Managing donors with iron deficiency)
We counsel donors with low Hb and send them to their 
own physicians and we provide educational material to all 
female donors in the age range of 18-50 years and all donors 
donating every fourth month or more frequently. In 2015 we 
started a cohort study, FIN Donor 10 000 with the goals of: (i) 
identifying/discovering the health effects of blood donation in 
the Finnish donor population, particularly with regards to iron 
status; and (ii) promoting the health of donors and preventing 
adverse events/effects, again mainly in relation to iron status.
Question 8 (Iron supplementation)
We provide iron supplementation to all female donors 
in the age range of 18-50 years and all donors donating 
every fourth month or more frequently. The first choice 
is HemoJern®(LongoVital, Lynge, Denmark) (dietary 
supplement) (350 mg hemoglobinpulver and 25 mg ferrous 
fumarate) (20 tablets): 1-3 tablets/day. The second choice is 
Retafer (ferrous sulfate, Fe++) 100 mg, (30 tablets): 1-2 tablets/
day. The Finnish Red Cross Blood Service bears the costs for 
iron supplementation.
Contact details
Johanna Castrén 
Medical Support in Blood Donation - Finnish Red Cross Blood Service
Kivihaantie 7
FI-00310 Helsinki, Finland
e-mail: johanna.castren@bloodservice.fi
FRANCE
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
a) Hb is assessed on a capillary sample before donation in the 
following conditions:
 - first donation;
 - last donation more than 2 years previously;
 - Hb near the threshold (≥12 and ≤12.5 g/dL for women 
and ≥13 and ≤13.5 g/dL for men) at the previous 
donation;
 -  Hb below the threshold (<12 g/dL for women and 
  <13 g/dL for men) at the previous donation;
 - physician order (clinical symptoms of anaemia).
b) Hb is measured as part of a blood cell count on a sample 
from each donation (results available after donation). 
Invasive method.
 A HemoCue® photometer is used to test the capillary 
samples.
Proportion of different methods:
- predonation testing: 21% of candidates;
- blood count: 100% of donations.
Use of venous blood
Venous blood is tested immediately pre-donation in the 
case of low Hb with the capillary test; in addition, a venous 
blood cell count including Hb concentration is determined for 
each donation.
Question 2 (Minimum Hb levels)
- Whole blood: 12 g/dL (females); 13 g/dL (males);
- platelets/plasma: 12 g/dL (females); 13 g/dL (males);
- red cells by apheresis: 14 g/dL (males and females).
Question 3 (Donor deferral rate for low Hb)
In 2014, the donor deferral rate due to low Hb was 1.82% 
for men and 4.81% for women.
Question 4 (Donation intervals and frequencies)
The minimum donation interval is 8 weeks for both male 
and female donors.
In a 1-year period, male donors may donate up to six times, 
and female donors up to four times.
Question 5 (Volume of whole blood donations)
The amount of whole blood collected must not exceed 13% 
of the total blood volume, and in any case must not exceed 
500 mL, blood samples not included. 
The volume collected for blood samples for laboratory 
testing ranges between 30 and 40 mL.
Question 6 (Assessment of iron stores)
Ferritin is only measured at the first donation of red blood 
cells by apheresis, and must be higher than 20 ng/mL to 
authorise further blood cell apheresis donations.
The French Blood Establishment (EFS) is willing to 
investigate studies about blood donor management on this 
subject. 
A study of the impact of donation frequency and Hb 
threshold is ongoing. The EFS is implementing an iron 
deficiency study in French overseas areas (the islands of 
Martinique and Guadeloupe).
Question 7 (Managing donors with iron deficiency):
Donors with a low Hb are deferred for 6 months and 
advised to consult their doctor. The similar management is 
applied in the case of iron deficiency.
Question 8 (Iron supplementation)
Not applicable.
Contact details
Bruno Danic
Etablissement Français du Sang Bretagne
rue Pierre Jean Gineste
35016 Rennes CEDEX, France
e-mail: bruno.danic@efs.sante.fr 
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Rachid Djoudi 
Geneviѐve Woimant
Etablissement Français du Sang
20 Avenue du Stade de France
93218 La Plaine Saint Denis, France
GERMANY
The data reported refer to the regional level (17 institutes for 
transfusion medicine and their mobile teams).
Question 1 (Hb determination in donor selection)
An invasive method, the Haemocue® (Hb Donor Checker) 
is used. Venous blood is not used.
Question 2 (Minimum Hb levels)
- Whole blood: males: ≥13.5 g/dL females: ≥12.5 g/dL;
- platelets/plasma: males: ≥13.5 g/dL females: ≥12.5 g/dL;
- red cells by apheresis: this is not done routinely. The 
minimum body weight of donors for red cell apheresis is 
70 kg; the minimum Hb levels are identical to whole blood.
Question 3 (Donor deferral rate for low Hb)
The donor deferral rate for low Hb is approximately 2%.
Question 4 (Donation intervals and frequencies)
The minimum interval is 56 days. The maximum number 
of donations for males is 6 times/year, whereas for females it 
is 4 times/year.
Question 5 (Volume of whole blood donations) 
The volume of donated blood is 500 mL, plus a maximum 
of 30 mL for laboratory testing.
Question 6 (Assessment of iron stores)
Iron stores are not assessed.
Question 7 (Managing donors with iron deficiency)
Donors with iron deficiency are given dietary advice; 
if regular donors (>2 donations/year), they are given iron 
supplementation, if they accept this. 
Question 8 (Iron supplementation)
Oral iron supplementation is supplied. The blood donor 
service bears the cost of this supplementation.
Contact details
Markus M. Mueller
Department Head Blood Donation 
Institute for Transfusion Medicine and Immunohaematology
University Clinics of the Johann Wolfgang Goethe University Frankfurt/Main
German Red Cross Blood Transfusion Service Baden-Wuerttemberg -Hessen
Sandhofstrasse 1 
60528 Frankfurt/Main, Germany
e-mail: m.mueller@blutspende.de
GREECE
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
Hb is determined by an invasive method. Only one blood 
establishment has been using a non-invasive method.
Use of capillary blood to assess the donors' Hb concentration: 
finger stick and a spectrophotometric method with portable 
devices (Hemocue®). 
Venous blood is used for the examination of Hb using 
haematology analysers for aphaeresis donors and in some 
females donating for first time.
 Question 2 (Minimum Hb levels)
- Whole blood: males ≥13.5 g/L, females ≥12.5 g/L;
- platelets/plasma: males ≥ 13.5 g/L and females ≥12.5 g/L;
-  red cells by apheresis is rarely performed: males ≥13.5 g/L.
Question 3 (Donor deferral rate for low Hb)
Data not nationally available. In large centers this rate is 
less than 3%.
Question 4 (Donation intervals and frequencies)
The minimum interval between whole blood donations is 
2 months for male and female donors. 
The maximum number of donations that can be collected 
from male donors in 1 year is four to six and for female donors 
three or four if the Hb screening is normal. 
The interval between a 2 units red cell apheresis must be 
4 months for males.
Question 5 (Volume of whole blood donations)
The acceptable range for the volume of one unit of 
donated whole blood donation  is 450±20 mL. The volume 
of the blood collected for laboratory testing ranges from 20 
to 30 mL depending of the method in use at the various blood 
establishments.
Question 6 (Assessment of iron stores)
We do not routinely measure ferritin level as a pre-donation test.
Question 7 (Managing donors with iron deficiency)
Donors with low hemoglobin are advised to increase 
donation intervals. Donors with iron deficiency are referred 
to their physicians. They are accepted again as donors after 
complete recovery of the iron deficiency. 
Question 8 (Iron supplementation)
Iron therapy in mostly administered orally. It is administered 
intravenously only if there is a contraindication to oral 
administration. Iron supplementation is prescribed by the 
physician of the blood transfusion service. The costs are 
covered by the blood donors' insurance fund.
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Contact details
Constantina Politis
Hellenic Center for Disease Control and Prevention (H.C.D.C.P.)
Hellenic Coordinating Haemovigilance Centre (SKAE)
10 Averof Str.
10433 Athens, Greece
e-mail: cpolitis@keelpno.gr
ITALY
The data reported refer to the local level.
Question 1 (Hb determination in donor selection)
We apply an invasive method for routine donor Hb 
screening. The most common method used is a finger prick test. 
Data are not available on the proportion of different methods.
We routinely use venous blood to assess pre-donation Hb 
by taking the sample from the sampling pouch at the beginning 
of the donation (results available after the donation), and 
occasionally before donation if the finger prick test is indicative 
of a low pre-donation Hb concentration. 
Question 2 (Minimum Hb levels)
- Whole blood: the minimum Hb level for male donors to 
donate is 135 g/L, while the minimum for female donors 
is 125 g/L; 
- platelets/plasma: when the interval between two plasma 
aphereses is more than 90 days, the minimum Hb level 
for male donors to donate is 125 g/L and for female 
donors is 115 g/L. The same standards as those for whole 
blood donation are applied to platelet apheresis with no 
exceptions; 
- red cells by apheresis: the minimum Hb level to undergo 
two-unit red blood cell apheresis is ˃ 150 g/L for both male 
and female donors.
In addit ion the minimal interval  between two 
consecutive two-unit red blood cell aphereses or between 
a two-unit red blood cell apheresis and a whole blood 
donation is 180 days.
Question 3 (Donor deferral rate for low Hb)
Data not available.
Question 4 (Donation intervals and frequencies)
The minimal interval between two consecutive whole 
blood donations is 90 days equally for male and female 
donors, but the maximum number of donations that can be 
collected in a 1-year period is four from male donors and 
female donors of non-childbearing age and two for female 
donors of childbearing age.  
Question 5 (Volume of whole blood donations)
The target volume of whole blood donations is 450 mL. 
The volume of the blood collected for laboratory testing must 
not exceed 40 mL.
Question 6 (Assessment of iron stores)
In accordance with Italian Law, we routinely measure 
serum ferritin once a year in regular blood donors to assess 
their iron stores.
Question 7 (Managing donors with iron deficiency)
As a first step, donors with iron deficiency are invited to 
lengthen the interval between whole blood donations. Iron 
supplementation is given only if the ferritin value declines 
significantly; this is not established by law but it is based on a 
clinical evaluation tailored on the donation programme (whole 
blood donation versus apheresis; male versus female).
Question 8 (Iron supplementation)
Iron supplementation is administered orally. The Italian 
National Health System bears the costs of the iron therapy.
Contact details
StefaniaVaglio
Dept. of Clinical and Molecular Medicine, Sapienza University of Rome 
Immunohaematology and Transfusion Medicine Unit
Azienda Ospedaliera Sant'Andrea
Via di Grottarossa 1039
00189 Rome, Italy
e-mail: stefania.vaglio@uniroma1.it
LATVIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
An invasive method, HemoCue®, is used to determine 
donor Hb. Venous blood is not used.
Question 2 (Minimum Hb levels)
-  Whole blood: males 135 g/L, females 125 g/L; 
-  platelets/plasma: males 135 g/L, females 125 g/L; 
-  red cells by apheresis: 140 g/L.
Question 3 (Donor deferral rate for low Hb)
The percentage of potential donors with a low Hb is 3% 
of males and 8.5% of females.
Question 4 (Donation intervals and frequencies)
In male donors the maximum number of donations per 
year is six (minimum interval, 9 weeks). In females the 
maximum number is four per year (minimum interval, 9 
weeks).
Question 5 (Volume of whole blood donations)
The volume of a whole blood unit is 450 mL and an 
additional 35 mL are taken for testing.
Question 6 (Assessment of iron stores)
Iron stores are not assessed.                                                 
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Question 7 (Managing donors with iron deficiency)
For donors with a low Hb level we recommend diet and 
at least a 1 month extension of the 9-week minimum interval 
between donations.
Question 8 (Iron supplementation)
Not applicable.
Contact details
Anita Daugavvanaga 
State Blood Donor Centre
Str. Selpils 9 
Riga, Latvia, Lv-1007
e-mail: anita.daugavvanaga@vadc.gov.lv
LITHUANIA
The data reported refer to national or institutional situations, 
as specified below.
Question 1 (Hb determination in donor selection)
Institutional level information (Public Institution, National 
Blood Centre): we use an invasive method for routine Hb 
screening. Only one method is used: capillary blood and a 
HaemoCue Hb 201 DM analyser.
We do not use venous blood for routine Hb screening. We 
use it for quality control, only four times per month for the 
whole blood donations and 30 times for filtrated red blood cells.
Question 2 (Minimum Hb levels)
National level information:
- whole blood: women 125 g/L, men 135 g/L;
- platelets/plasma: women 125 g/L, men 135 g/L;
- red cells by apheresis: women 145 g/L, men 140 g/L (we 
do not take red cells by apheresis in our centre).
Question 3 (Donor deferral rate for low Hb)
Institutional level information: donors are deferred for 1 
month if they have a low Hb level.
With regards to 2014, among males there were 646 
deferrals (1.42% of presenting donors or 0.91% of presenting 
donations) and among females there were 1785 deferrals 
(3.92% of presenting donors or 2.52% of presenting donations).
Question 4 (Donation intervals and frequencies)
National level information: the minimal interval between 
whole blood donations is 2 months for both males and females. 
The maximum number of donations that can be collected in 
a 1-year period from male donors is six, while the maximum 
number from female donors is four.
Question 5 (Volume of whole blood donations)
Institutional level information: the acceptable range for the 
volume of whole blood donations is 405-495 mL. The volume 
for laboratory testing is 20 mL. 
Question 6 (Assessment of iron stores)
Institutional level information: we do not measure ferritin 
routinely. We are not aware of any research on donor iron 
stores in our country.
Question 7 (Managing donors with iron deficiency)
Institutional level information: if the Hb level is low, we 
defer the donor for 1 month. The doctor gives dietary advice 
and if necessary refers the donor to his or her GP for a full 
blood count and treatment.
Question 8 (Iron supplementation)
Institutional level information: we do not give iron 
supplementation.
Contact details
EditaVilutyte
Public Institution National Blood Centre 
Zolyno 34
LT-10210 Vilnius, Lithuania
e-mail: e.vilutyte@kraujodonoryste.lt
LUXEMBOURG
The data reported refer to the national data from 2010.
Question 1 (Hb determination in donor selection)
In Luxembourg, the country's blood component needs 
are covered by approximately 20,000 whole blood donations, 
1,000 plateletaphereses and 5,000 plasmaphereses for contract 
fractionation, all collected by one single blood establishment, 
with one fixed site and two mobile teams. 
Low iron stores and iron deficiencies in blood donors have 
always been a concern in Luxembourg.
First-time donors are not accepted immediately for 
donation: they become "donor candidates". They undergo the 
extended medical questionnaire, by a medical doctor and blood 
samples are drawn (including a tube for a 15-parameter blood 
count) without a donation being taken.
In repeat donors, the eligibility is mainly based on 
haematological results of the past donations and on the recent 
donor history. If there is a "trigger event", a pre-donation check 
is performed with HemoCue® (especially in the mobile drives) 
and a Coulter STKS© (Beckman Coulter, Hialeah, FL, USA) 
(full blood count with 15 parameters in the blood centre).
At the beginning of the donation, a blood sample is 
collected from the diversion pouch of the collection kit to run 
a full blood count on the blood cell counter.
Invasive or non-invasive method
Invasive: if a pre-donation Hb test is required, a venous 
blood sample is taken.
Non-invasive: if no pre-donation Hb test is required, the 
routine testing is done using a blood sample taken from the 
diversion pouch of the collection kit, after venipuncture has 
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been performed for the purpose of the donation. See above 
for: before and after donation, fixed site and mobile drives.
Method specification
In general, the results of blood counts of former blood 
donations are the basis for donor acceptability and these data 
are found on the donor history file slip.
Proportion of different methods
At a national level, all procedures are the same as there 
is only one blood establishment in Luxembourg; two-thirds 
of all whole blood collections are taken in the fixed blood 
centre, one-third in the mobile drives. About 10-15% of 
donors coming to donate undergo a pre-donation Hb check, in 
the fixed centre with the blood counter, on the mobile drives 
with the HemoCue® instrument. All donations are rechecked 
systematically on a blood sample taken from the diversion 
pouch filled at the beginning of the donation (the latter is not 
considered invasive although there is venipuncture but for the 
purpose of collecting a unit of whole blood).
Use of venous blood
On all donations, a full blood count is performed on venous 
blood taken at the start of the donation. All haematology results 
are reviewed by a medical doctor. A computer programme 
allows for electronic selection and classification of the values 
of 15 haematological parameters and facilitates the work of 
the physician in charge of assessing a huge amount of data 
every day. If this evaluation gives suspicious results for a 
donor, additional steps may be ordered according to predefined 
procedures. 
In cases of mild iron depletion (Hb and haematocrit 
are normal, but red cell morphology indices are lowered), 
additional ferritin and total iron binding capacity tests are 
performed on the existing blood sample. The red blood 
cell indices used are: mean corpuscular volume, mean 
corpuscular Hb, mean cell Hb concentration and red cell 
morphology index, giving the distribution curve of red 
blood cells). 
In cases of severe iron deficiency (Hb and haematocrit are 
significantly lowered and the red blood cell indices are anyway 
abnormal), the donor is recalled and has a targeted and detailed 
history taken, has new blood samples drawn and gets some 
counselling on iron deficiency. 
Question 2 (Minimum Hb levels)
- Whole blood: for female donors >125 g/L, for male donors 
>135 g/L;
- platelets/plasma: for female donors >115 g/L, for male 
donors >125 g/L;
- red cells by apheresis: this type of procedures is rarely 
performed as we believe that in Luxembourg it is not 
necessary and it is not cost-effective.
Question 3 (Donor deferral rate for low Hb)
In 2010, the overall deferral rate for whole blood donors 
was 6% in the blood centre and 8% on the mobile drives 
(temporary and permanent deferrals for any cause taken 
together). Of these deferrals, <10% were due to low Hb or 
abnormal haematology results, suspicious of iron deficiency. 
In that year, 17 donors were deferred permanently because 
of repeated Hb failures (0.63% of 2,682 permanent deferrals 
occurring during that year).
In 2010, the deferral rates were not separated according to 
whether the donors were female or male.
The data for plasma/platelet-pheresis donors are not 
really relevant in the present context, because these donors 
are selected exclusively for the plasma-/cytapheresis 
programme and both donor pools (whole blood and 
apheresis) are kept separate. These dedicated plasma donors 
(donating only plasma and/or platelets and plasma) are 
selected based on: gender (mostly female donors), low body 
weight (<50 kg), confirmed low iron stores, blood groups 
(preferentially blood groups B+ and AB+) and also donors 
with travel to malaria areas (during their temporary deferral 
from whole blood donations).
Question 4 (Donation intervals and frequencies)
For female whole blood donors, the minimum interval 
between donations is 4 months (with a maximum of 3 whole 
blood donations per year). For male whole blood donors, the 
minimum interval is 3 months (with a maximum of 4 whole 
blood donations per year). 
For plasmapheresis donors, the minimum interval between 
donations is 1 month (with a maximum of 12 plasma donations 
a year).
Question 5 (Volume of whole blood donations)
Whole blood collection is standardised at 500 mL±10% 
plus 30 mL for blood samples. 
For plasmapheresis donations, the volume is adapted to 
the donor's body weight and blood count (from 500 mL up to 
a maximum of 750 mL per plasma donation).
Question 6 (Assessment of iron stores)
Specific tests for iron reserves are not performed 
systematically (i.e. with each donation collected), but these 
tests are routine as supplementary tests in suspected cases of 
weakness/depletion of iron stores. A detailed algorithm is not 
available to this author. The frequency of iron deficiency in 
whole blood donors is directly reflected by and correlated with 
the donor deferral rates for this suspension (mostly temporary). 
Raw data on the iron issue in donors are available, but not 
used for research.
Question 7 (Managing donors with iron deficiency)
The approach for each iron-depleted donor is customised, 
individualised and depends on different aspects. In female 
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whole blood donors with iron deficiency, an initial temporary 
deferral for 6-12 months is applied; this may be extended 
according to the results of repeat testing. In relapsing cases 
of iron deficiency, permanent deferral is considered or, as 
an alternative, the donor is offered the possibility of being 
a plasmapheresis donor (with flexible volume collected and 
frequency of plasma donations).
Question 8 (Iron supplementation)
Iron supplementation is administered orally (drugs of 
different brands are used in order to ensure best tolerated oral 
treatment). If the blood centre hands over iron tablets to a 
donor, these are paid for by the blood centre. If a blood donor 
consults his doctor who prescribes iron supplement therapy, 
the costs for that medication is covered by the Social Security 
Service of Luxembourg.
Comments and suggestions
Iron deficiency in blood donors has been underestimated 
for a long time. The vast majority of resources have been 
concentrated on recipient safety, whereas donor safety was 
taken for granted by many. In my view, it is more than urgent to 
balance safety concerns and measures for donors and recipients 
at the same level. Iron deficiency is only one issue in the 
context of donor safety: others are delayed vasovagal reactions 
with severe accidents, protein depletion with aggressive 
plasmapheresis programmes, osteoporosis following repeated 
apheresis procedures, long-term side effects of mobilisation of 
peripheral progenitor cells for apheresis harvesting.
Contact details
Jean-Claude Faber
Retired Medical Director of Luxembourg Blood Services
Luxembourg
e-mail: jean.claude.faber@numericable.lu
MALTA
The data reported refer to the national level (there is only one 
Blood Establishment in the Maltese Islands, the Malta National 
Blood Transfusion Service).
Question 1 (Hb determination in donor selection)
An invasive method is used to determine Hb concentration.
A photometric method of measurement is applied to a drop 
of capillary blood obtained by finger prick. Venous samples are 
tested  by a complete blood count analyser machine.
The photometric measurement of capillary blood is 
used for 100% of whole blood donors. Hb is assessed by a 
complete blood count of a venous sample in the following 
circumstances:
- additional testing in the case of failing an initial screen;
- pre-donation for platelet donors (a separate venipuncture for 
a venous sample is required for the platelet count). 
Question 2 (Minimum Hb levels)
- Whole blood: males 13.5 g/dL, females 12.5 g/dL;
- platelets/plasma: apheresis platelet donations: males 
 13.5 g/dL, females 12.5 g/dL. Plasma is not collected by 
apheresis:
- red cells by apheresis: not collected.
Question 3 (Donor deferral rate for low Hb)
The total deferral rate from whole blood donation in 2014 
was 24.05%. Of these deferrals, 18.52% were due to low Hb 
levels. This translates into 4.45% of total deferrals.
Of the total deferrals due to low Hb, 68.80% were female 
donors (686 donors) and 31.19% were male donors (311 donors).
Question 4 (Donation intervals and frequencies)
The minimal interval is 3 months for males and 4 months 
for females. The maximum number of donations in 1 year is 
four for males and three for females.
Question 5 (Volume of whole blood donations)
The volume of a whole blood unit is 475 mL±10%. Another 
10-15 mL are collected for testing.
Question 6 (Assessment of iron stores)
Ferritin is assessed in regular donors who request other 
routine testing offered by the Malta National Blood Transfusion 
Service. However, this is not standard practice for all donors. 
Currently there is no formal research on this issue in Malta, 
although there has been some in the past few years.
Question 7 (Managing donors with iron deficiency)
Donors with iron deficiency are given dietary advice, oral 
iron supplementation, prescribed as necessary, and advised to 
leave more time between donations.
Question 8 (Iron supplementation)
Any iron supplementation is administered orally.
The donor bears the cost of iron therapy.
Contact details
Denise Borg-Aquilina
Malta National Blood Transfusion Service
G'Mangia Hill, Pietà, Malta
e-mail: denise.borg-aquilina@gov.mt
The NETHERLANDS
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
Hb is determined by an invasive method: finger stick and 
Hemocue®. Only this method is used.
Hb is not determined from venous blood, except for quality 
control purposes and special requests, e.g. piano players.
© 
SIM
TI 
Se
rvi
zi 
Srl
All rights reserved - For personal use only 
No other use without premission
18
Vuk T et al
Blood Transfus DOI 10.2450/2016.0101-16
Question 2 (Minimum Hb levels)
- Whole blood: males 8.4 mmol/L, females 7.8 mmol/L;
- plate le ts /plasma:  males  8 .4  mmol/L,  females
 7.8 mmol/L;
- double red cells by apheresis:  ≥ 8.7 mmol/L, 
haemochromatosis patients only.
Question 3 (Donor deferral rate for low Hb)
Females 5% deferral, males 2% deferral; mean deferral rate 3.3%.
Question 4 (Donation intervals and frequencies)
The minimal interval between donations is 56 days. Male 
donors can give a maximum of five whole blood donations/
year, female donors can give a maximum of three whole blood 
donations/year.
Question 5 (Volume of whole blood donations)
The volume of a whole blood unit is 450-550 mL +30 mL 
collected into the deviation pouch/test tubes.
Question 6 (Assessment of iron stores)
No ferritin measurement.
Question 7 (Managing donors with iron deficiency)
Only temporary deferral or permanent deferral based 
on donor data and/or reduction of the maximal number of 
donations/year.
Question 8 (Iron supplementation)
No iron supplementation is administered.
Comments and suggestions
For the future a personalised donor interval based on 
previous Hb would contribute to the prevention of deferrals 
due to low Hb.
Contact details
Peter J.M. van den Burg
Transfusion Medicine Sanquin
Plesmanlaan 125
1066 CX Amsterdam, The Netherlands
e-mail: p.vandenburg@sanquin.nl
Arlinke Bokhorst
Medical Donor AffairsSanquin
Plesmanlaan 125
1066 CX Amsterdam, The Netherlands
e-mail: a.bokhorst@sanquin.nl
POLAND
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
Invasive or non-invasive method
Both invasive and non-invasive methods are applied for 
routine donor screening.
In general, a total blood count from venous blood (separate 
venipuncture) before donation is determined once a year in 
regular donors. In routine practice, the Hb concentration in 
repeat blood donors is determined before each donation by 
means of a haemoglobinometer on capillary blood or using 
the non-invasive method.
Method specification
We determine either Hb level or complete blood count 
following respective European Union Directives. Blood 
Transfusion Centres determine the complete blood count 
using haematology analysers or Hb concentration only using 
a haemoglobinometer. During mobile blood collections, Hb 
concentration is determined. The non-invasive method is 
performed with an optical measurement device combined with 
a finger-attached sensor probe. The measurement is performed 
directly on the donor's finger. This involves no drawing of a 
blood sample.
Proportion of different methods
Difficult to estimate.
Use of venous blood
Venous blood is used to assess the donor's Hb concentration 
pre-donation.
Question 2 (Minimum Hb levels)
The minimum Hb concentration is the same for whole 
blood, platelet and plasma donors and is 13.5 g/dL for male 
donors and 12.5 g/dL female donors. The minimum Hb 
concentration for donors of red cells collected by double 
erythroapheresis is 14.0 g/dL for men and women. 
Question 3 (Donor deferral rate for low Hb)
The donor deferral rate in 2014 was 104.99/1,000 persons 
presenting for donation.
The donor deferral rate in 2013 was 107.43/1,000 persons 
presenting for donation. 
Separate data for male and female donors are not 
available.
Question 4 (Donation intervals and frequencies)
The minimum interval for whole blood donations is
8 weeks for both males and females. 
The maximum number of donations that can be collected 
per year is six for males and four for females.
Question 5 (Volume of whole blood donations)
The volume of blood donation is 450 mL ±45 mL and the 
volume for laboratory testing is approximately 40 mL.
Question 6 (Assessment of iron stores)
Iron stores are not assessed.
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Question 7 (Managing donors with iron deficiency)
In the case of a Hb level below the limit we defer the 
donor, give dietary advice and refer the donor to his or her 
GP for prescription of iron supplementation and monitoring 
of its effect.
Question 8 (Iron supplementation)
Iron supplementation is given orally. Public funds cover 
the cost of this iron therapy. 
Contact details
Ryszard Pogłód
Clinical Transfusion Medicine Laboratory
Department of Transfusion Medicine
Institute of Haematology and Transfusion Medicine 
Indiry Gandhi 14
02-776 Warsaw, Poland
e-mail: rpoglod@ihit.waw.pl
Jolanta Antoniewicz-Papis
Institute of Haematology and Transfusion Medicine
Indiry Gandhi 14
02-776 Warsaw, Poland
e-mail: jpapis@ihit.waw.pl, j.antoniewiczpapis@gmail.com
PORTUGAL
The data reported refer to the Blood and Transplantation 
Centre in Coimbra.
Question 1 (Hb determination in donor selection)
Hb levels are measured invasively using the HemoCue® 
301 system on capillary blood from a finger.
Hb is measured in venous blood in donors undergoing 
apheresis as part of the pre-donation complete blood count 
using a sample collected before the apheresis procedure and 
in first-time whole blood donors as post-donation testing of a 
sample from an integrated sample pouch at the beginning of 
the collection.
Question 2 (Minimum Hb levels)
- Whole blood: males 13.5 g/dL, females 12.5 g/dL;
- platelets/plasma: males 13.5 g/dL, females 12.5 g/dL;
- red cells by apheresis: males 13.5 g/dL females 12.5 g/dL.
Question 3 (Donor deferral rate for low Hb)
- Males: 1.11% (411/37,031) 0.54% (411/75,502);
- females: 5.49% (2112/38,470) 2.8% (2112/75,502).
Question 4 (Donation intervals and frequencies)
The minimum interval between donations for females is 
4 months, who can make a total of three donations per year.
The minimum interval between donations for males is 3 
months, who can make a total of four donations per year.
Question 5 (Volume of whole blood donations)
The volume of a whole blood unit is 450 mL±10%; an 
additional 35 mL are collected for laboratory tests.   
Question 6 (Assessment of iron stores)
We do not perform routine measure of ferritin. There was 
a group that did some research on donor iron stores.
Question 7 (Managing donors with iron deficiency)
A donor with low Hb usually has counselling, with the 
suggestion to increase donation intervals and dietary advice. 
In repeated cases, the donor is advised to visit the family 
doctor. 
Question 8 (Iron supplementation)
We do not prescribe iron supplements at donation sessions.
Contact details
Mario Muon
Centro de Sangue e da Transplantação de Coimbra
Quinta da Vinha Moura, S. Martinho do Bispo
Coimbra, Portugal
e-mail: Mario.chin@ipst.min-saude.pt
ROMANIA
The data reported refer to the Blood Transfusion Centre in 
Bihor.
Question 1 (Hb determination in donor selection)
We determine the Hb level on capillary blood from all 
donors, pre-donation using HemoCue® and on venous blood 
using a semi-automated medical device (pre- or post-donation).
Venipuncture is always performed in the case of an 
apheresis procedure and is performed in certain situations to 
compare capillary and venous Hb levels.
After the eligibility procedure (including the already 
mentioned ways of determining Hb) blood (for screening 
tests) is collected from the sampling pouch at the beginning 
of blood collection.
 Question 2 (Minimum Hb levels)
We perform whole blood collection and platelet apheresis.
For whole blood collection, the thresholds are 12.5 g/dL 
for females and 13.5 g/dL for males.
For platelet apheresis:
- performed on MCS+ devices, the thresholds are 12.5 g/dL 
for females and 13.5 g/dL for males;
- performed on a TRIMA device, the thresholds are 12.0 g/dL 
for females and 13.0 g/dL for males.
Question 3 (Donor deferral rate for low Hb)
From the total number of potential donors (13,500), 1,282 
were rejected (9.49%).
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From the total number of rejected potential donors (1,282), 
393 (30.6%) were rejected according to Hb level: 218 females 
(17.0%) and 175 males (13.6%).
Question 4 (Donation intervals and frequencies)
- 70 days for whole blood collection, in males (maximum 5 
donations/year).
- 90 days for whole blood collection, in females (maximum 
4 donations/year).
Question 5 (Volume of whole blood donations) 
The volume of whole blood collected is 450 mL±10%, as 
indicated on blood bags.
About 18 mL of blood are collected at each donation 
session for laboratory testing.
Question 6 (Assessment of iron stores)
Never. I do not have any data regarding national research 
on iron deficiency.
Question 7 (Managing donors with iron deficiency)
We either refer the potential donors to family doctors 
or recommend iron substitutes; according to Hb levels and 
evolution we recall the potential donor, after a certain period 
of time, to check the Hb level and we also prolong the interval 
between donations.
Question 8 (Iron supplementation)
Iron supplementation is given orally, if indicated by us.
The iron supplementation is prescribed by either the blood 
transfusion service (when the cost is borne by the donor) or by 
the donor's physician (the cost is borne by the donor, or by the 
Health Insurance System).
Contact details
Olivia Ligia Burta
Bihor Blood Transfusion Centre
Louis Pasteur 30, 
Oradea, Bihor County, Romania
e-mail: oliviaburta@yahoo.com
SLOVAKIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
In Slovakia, an invasive method is used for donor Hb 
screening before donations. The haemogram is controlled 
before each donation. In blood establishments venous blood 
is used in a Sysmex instrument and the sample is taken by 
separate venipuncture before donation. At mobile collection 
sites the Hb level is checked by Haemocue® on capillary 
blood, and then is re-checked on venous blood in the blood 
establishment by a Sysmex instrument on a sample taken from 
the integrated sampling pouch at the beginning of the donation.
Question 2 (Minimum Hb levels)
Minimum Hb levels for whole blood, plasma and platelet 
donations are 135 g/L for male donors and 125 g/L for female donors. 
For red cell apheresis in males, the minimum Hb level is 150 g/L.
Question 3 (Donor deferral rate for low Hb)
We do not collect data concerning the deferral rate due to 
low Hb level.
Question 4 (Donation intervals and frequencies)
The minimal interval between two whole blood donations 
is 3 months in males and 4 months in females. Males can give 
their blood four times/year and females three times/year.
Question 5 (Volume of whole blood donations)
We take 450 mL of blood per donation. The volume of 
blood for samples is about 25 mL.
Question 6 (Assessment of iron stores)
We do not routinely measure the ferritin level in donors. 
Donors are selected by a medical doctor in the blood 
establishments. The doctor has the blood count results before 
the donation. This physician informs the donor about the 
results, and asks the donor to go to his or her family doctor if 
there is evidence of anaemia or other blood count pathology. 
The blood establishment doctor can also investigate anomalies 
(measure ferritin, B12, folic acid) and can give iron treatment 
to the donor. Males are usually asked to see their doctors while 
females can be provided iron treatment directly in the blood 
establishment. In this case, the iron treatment is free and paid 
by the blood establishment. The donor is deferred for a certain 
period (6 months or 1 year) depending on the level of Hb. 
Practices may differ in different blood establishments. There is 
no legislative requirement regarding control of the ferritin level.
If a low Hb level is detected after the donation (normal Hb 
level before donation, but low Hb level in venous blood), the 
donor is informed by letter.
Question 7 (Managing donors with iron deficiency)
Donors with repeated low ferritin or Hb levels are invited 
to donate platelets or plasma or to decrease the frequency of 
donations or they are refused definitively.
Question 8 (Iron supplementation)
If iron substitution is given by a blood establishment, it is 
usually administered orally. 
Contact details
Jana Rosochová,
Expert of the Ministry of Health in Transfusion 
National Transfusion Service
Limbová 3
833 14 Bratislava, Slovak Republic
e-mail: rosochova@ntssr.sk
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SLOVENIA
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
Only invasive methods are used to determine Hb.
Hb concentration is determined by HemoCue® on capillary 
blood for whole blood and plasma donations. For platelet 
apheresis donations, the sample is taken by separate 
venipuncture before donation for a complete blood count using 
the Coulter method.
The Hemocue method is used in approximately 98% of 
cases, and the Coulter method in the remaining 2%.
Question 2 (Minimum Hb levels)
- Whole blood: males 135g/L  and females 125 g/L;
- platelets/plasma: same as above;
- red cells by apheresis: not done in Slovenia.
Question 3 (Donor deferral rate for low Hb)
The rate in  2014 was approximately 30%. Separate data 
are not available for males and females.
Question 4 (Donation intervals and frequencies)
The minimum donation interval for males is every 3 
months (4 collections) whereas for females it is every 4 months 
(3 collections). Donations can be made 2 weeks before the end 
of these intervals if the Hb level acceptable.
Question 5 (Volume of whole blood donations)
Whole blood: 450 mL±10% (theoretically 405-495 mL, 
but maximum value never taken in practice; in reality we only 
collect from 405 mL to 450 mL, especially for first-time donors 
and young donors). 
The volume of blood taken for laboratory testing is 23 mL 
(standard volume into test-tubes).
Question 6 (Assessment of iron stores)
Iron stores are not assessed, but we are planning to 
introduce point-of-care ferritin testing in 2016 as a pilot study 
for some donors. 
Question 7 (Managing donors with iron deficiency)
Donors with a low Hb (below 115 g/L) are referred to their GP.
For female donors with a Hb level 115-125 g/L and male 
donors with a Hb below 135 g/L, donation is postponed at 
least 1 month, and the donors are given counselling and dietary 
advice. No treatment is prescribed.
Question 8 (Iron supplementation)
Iron supplementation is not given.
Contact details
Polonca Mali
Blood Donor Selection and Collection Unit
Blood Transfusion Centre of Slovenia
Slajmerjeva 6
1000 Ljubljana, Slovenia
e-mail: polonca.mali@ztm.si
SPAIN
The data reported refer to the istitutional/regional level.
Question 1 (Hb determination in donor selection)
Hb is determined with an invasive method, but we are 
moving to a non-invasive method in January -June 2016. The 
copper sulphate method is used (density 1.053 for women and 
1.055 for men).
Hb is determined on venous blood only when blood donors 
are considered as non-eligible for blood donation. In those cases 
complete venous testing is performed, including tests related 
to iron stores. When iron depletion is suspected for the first 
time, the donors are given the report and the recommendation 
to visit a GP for further investigation and iron therapy; the 
donor is deferred for 6 months. At the following donation 
a ferritin control is added to the pre-donation screening.  In 
regular donors already studied for iron depletion, and once 
other reasons of blood losses have been discarded, the number 
of blood donations per year is adjusted to one or two depending 
on the individual case. 
Question 2 (Minimum Hb levels)
- Whole blood: 12.5 g/dL for females and 13.5 g/dL for 
males;
- platelets/plasma: 12.5 g/dL for females and 13.5 g/dL for 
males;
- red cells by apheresis: 12.5 g/dL for females and 13.5 g/
dL for males.
Blood donors with Hb below these levels can be accepted 
depending on the instructions of the responsible physician. 
Question 3 (Donor deferral rate for low Hb)
The deferral rate for low Hb was 0.89% of all males 
offering to donate blood but 0.81% of male donors who had 
made one or more previous blood donations. The corresponding 
figures for females were 3.77% and 2.70%.
Question 4 (Donation intervals and frequencies)
The minimum donation interval is 2 months for both males 
and females with a maximum of three blood donations/year 
for females and four for males.
Question 5 (Volume of whole blood donations)
The volume of a whole blood unit is 411-495 mL. The 
volume of blood for laboratory testing is 24 mL.
Question 6 (Assessment of iron stores)
See answer to question 1.
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Question 7 (Managing donors with iron deficiency)
See answer to question 1. We sometimes start iron therapy 
but usually the problem is resolved just by decreasing the 
frequency of blood donation.
Question 8 (Iron supplementation)
Iron supplementation is administered orally. The costs are 
borne by the Regional Health System.
Contact details
Miguel Angel Vesga
Centro Vasco de Transfusión y Tejidos Humanos (CVTTH)
Bilbao, Spain
e-mail: MIGUELANGEL.VESGACARASA@osakidetza.eus
SWEDEN
The data reported refer to the national level.
Question 1 (Hb determination in donor selection)
No blood donation is accepted from potential new donors. First, 
the history is taken, a physical evaluation performed and laboratory 
samples are collected for acceptance or deferral of the donor. 
In registered donors, at blood donation the Hb is determined 
on a venous EDTA-blood sample taken from the sample pouch 
of the blood bag after the donation. Test results are available 
after the donation in accordance with Swedish standards. 
Non-invasive methods are under evaluation. 
Question 2 (Minimum Hb levels)
- Whole blood: males 135 g/L or 125 g/L if taken after the 
donation, females 125 g/L or 115/g/L if taken after the 
donation;
- platelets/plasma: no difference according to the Standards;
- red cells by two-unit apheresis collection: 140g/L.
Question 3 (Donor deferral rate for low Hb)
Such data are not collected. The pre-qualification of donors 
leads to non-acceptance of approximately 20% of female and 
4% of male applicant donors. 
Question 4 (Donation intervals and frequencies)
The minimum interval is 12 weeks. The maximum numbers 
of blood donation per year are four for males and three for 
females.
Question 5 (Volume of whole blood donations)
The volume is 450 mL±10% and a maximum of 
500 mL, including blood samples for laboratory testing, may be 
collected. Furthermore, the amount of blood collected must not 
exceed 13% of the donor's blood volume calculated according 
to sex, height and body weight.
Question 6 (Assessment of iron stores)
There are different practices in Sweden and efforts are 
being made to harmonise them. The more ambitious blood 
establishments test ferritin levels at pre-qualification and at 
regular intervals thereafter. In Uppsala, the cut-off level for 
accepting donors and donations is 25 μg/L for males and 
20 μg/L for females. This is equal to the lower reference level 
for men but higher than that for women (20 μg/L instead of
10 μg/L).  Applying these levels together with Hb level 
will defer about 30% of women and 5% of men in the pre-
qualification stage.
Question 7 (Managing donors with iron deficiency)
Iron supplementation is provided and instead of a donation 
the donor is invited to a control visit at which a questionnaire 
is completed and blood samples taken for tests. Evaluation of 
the information leads to appropriate counselling. 
Question 8 (Iron supplementation)
Iron supplementation is given orally. The costs are covered 
by the Blood Establishment. 
Contact detail
Karin Schneider, Donor Selection and Care
Rut Norda, Clin Immunology and Transfusion Medicine
Uppsala University Hospital
751 85 Uppsala, Sweden
e-mail: rut.norda@akademiska.se
UNITED KINGDOM
These data apply to NHS Blood and Transplant (NHSBT) 
which is the organisation responsible for blood collection in 
England and North Wales and these data apply to the whole 
organisation.
Question 1 (Hb determination in donor selection)
Invasive testing is used with a copper sulphate screening 
test and two different solutions with specific gravity set to 
detect males with Hb 135g/L and females 125g/L. Donors who 
fail the copper sulphate screening test have a Hb measurement 
on a venous blood sample using the HemoCue®. They are 
accepted if the Hb ≥135 g/L for males and ≥125 g/L for females. 
Question 2 (Minimum Hb levels)
- Whole blood: males 135 g/L, females 125 g/L;
- platelets - males 135 g/L, females 125 g/L;
- double red cell apheresis is not performed at present in the 
NHSBT.
Question 3 (Donor deferral rate for low Hb)
- The 2014 rate for males was 152 per 10,000 attendances.
- The 2014 rate for females was 406 per 10,000 attendances.
Question 4 (Donation intervals and frequencies)
Our UK Donor Selection guidelines state the following:
"A minimum interval of 12 weeks between donations 
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should normally be observed. Donors who regularly attend at 
intervals of less than 16 weeks should be informed that they are 
at increased risk of iron deficiency. They should be advised to 
reduce their frequency of donation to an average of 16 weeks 
or more. Donors with genetic haemochromatosis may donate 
at intervals of less than 12 weeks".
We advise our donors that they should not give more than 
seven whole blood donations in 2 calendar years. However 
this is not enforced by our computer system.
We currently have approximately 50,000 blood donors 
registered in the INTERVAL study who donate at 8, 10, 12 
weeks (males) or 10, 12, 14 weeks (females).
Question 5 (Volume of whole blood donations)
A whole blood donation is 475 mL ±10% and the sample 
pouch contains 20-35 mL. 
Question 6 (Assessment of iron stores)
The NHSBT does not routinely measure serum ferritin 
levels. 
The INTERVAL study is currently underway in the 
NHSBT. Part of this study is to look at iron stores. 
Question 7 (Managing donors with iron deficiency)
As we do not make a specific diagnosis of iron deficiency 
in our donors we do not manage this directly.  
- Donors with a HemoCue® result of 125-134 g/L (males) 
and 115-124 g/L (females) are deferred for 3 months.
- Donors who have a HemoCue® result below 125 g/L 
(males) and 115 g/L (females) are deferred from donation 
for 12 months and referred to their GP for investigation 
and treatment.
- Male donors with a HemoCue® result <100 g/L and female 
donors with a HemoCue® result <80 g/L are advised to 
make an urgent appointment to see their GP.  
Question 8 (Iron supplementation)
The NHSBT does not provide iron supplementation to 
blood donors.
Contact details
Nicky Anderson, 
Associate Medical Director Blood Donation
NHS Blood and Transplant
500 North Bristol Park
Filton BS34 7QH, UK
e-mail: nicky.anderson@nhsbt.nhs.uk
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